Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value

$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck consolidated Other Countries Revenue ($M) ($M)

Postgres DB segment_values

Quarterly Annual

Latest, FY2025

2,878

Period ended Dec 31, 2025

Change on a year earlier

+12.5%

2,559 in FY2024

History

15 years

Since FY2011

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Consolidated Other Countries Revenue ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	2,878	+12.5%	Form 10-K (filed 2026-02-24) ↗
FY2024	Dec 31, 2024	2,559	+21.6%	Form 10-K (filed 2025-02-25) ↗
FY2023	Dec 31, 2023	2,104	-18.1%	Form 10-K (filed 2024-02-26) ↗
FY2022	Dec 31, 2022	2,568	+110.3%	Form 10-K (filed 2023-02-24) ↗
FY2021	Dec 31, 2021	1,221	+18.9%	Form 10-K (filed 2022-02-25) ↗
FY2020	Dec 31, 2020	1,027	-19.5%	Form 10-K (filed 2022-02-25) ↗
FY2019	Dec 31, 2019	1,275	+25.6%	Form 10-K (filed 2022-02-25) ↗
FY2018	Dec 31, 2018	1,015	-28.6%	Form 10-K (filed 2021-02-25) ↗
FY2017	Dec 31, 2017	1,422	-2.4%	Form 10-K (filed 2018-02-27) ↗
FY2016	Dec 31, 2016	1,457	-26.4%	SEC Filing ↗
FY2015	Dec 31, 2015	1,979	+39.6%	SEC Filing ↗
FY2014	Dec 31, 2014	1,418	-8.8%	SEC Filing ↗
FY2013	Dec 31, 2013	1,555	-4.0%	Form 10-K (filed 2014-02-27) ↗
FY2012	Dec 31, 2012	1,619	-17.7%	Form 10-K (filed 2014-02-27) ↗
FY2011	Dec 31, 2011	1,967	–	Form 10-K (filed 2014-02-27) ↗

Cite this data

StockData. (2026). Merck Consolidated Other Countries Revenue ($M) ($M), annual FY2011–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_other_rev

See every metric in the Merck KPI table. Data updated Oct 26, 2026.